 
            
    
    
  
New product filings to FDA included stronger safety features and larger technological advances
 
            
    
    
  
That approach, closer to an opt-out, beat three nudges, or opt-ins at encouraging younger people to get tested
 
            
    
    
  
Model tells schedulers which anesthesiologists should be on call or on-site at specific times
 
            
    
    
  
Paperwork issues at physical therapy providers curtail care more often for minority and low-income patients
 
            
    
    
  
Behavioral nudges reduced doctors’ overprescribing and overtesting of older patients
 
            
    
    
  
Tolerating a low level of transmission just might be the better strategy
 
            
    
    
  
The figure is a subset, not covering huge expense of extended patents on high-priced biologics like Humira
 
            
    
    
  
A model vastly outperforms predictions based on prior hospital data
 
            
    
    
  
Management and real estate deals to owners’ firms siphon off most profits
 
            
    
    
  
Nudges already proven to work in the real-world increased uptake of COVID-19 boosters; nudges based on lab findings and expert insights, not so much
 
            
    
    
  
In LA, doctors who lose a patient to opioid overdose get a letter from the coroner; tweaking that letter had a substantial impact
 
            
    
    
  
The shift lends credibility to medicines vs. trials that exclude people 65 and older
 
            
    
    
  
Years after a paper goes unpublished, it’s fodder for a major Federal Trade Commission proposal
 
            
    
    
  
U.S. efforts to encourage transparency widely ignored by companies
 
            
    
    
  
An upfront fee for taking Medicaid patients could shorten stays
 
            
    
    
  
The ethics of asking brain surgery patients to allow unrelated research while on the operating table